# Professor Belvisi joins from AstraZeneca, where she served as Senior Vice President, Research & Development, Respiratory & Immunology.

*biotech · news · 2026-04-10 · The Manila Times*

## Key points

- Professor Belvisi will establish and lead a new UK research site for Ailux.
- Ailux aims for its first internally developed biologics to enter clinical trials by 2027.
- Belvisi led tozorakimab from preclinical research to Phase 3, achieving landmark COPD trial results.
- Ailux is transitioning from AI-native biologics discovery to a fully integrated drug development organization.

**Companies:** AstraZeneca, Eli Lilly, Johnson & Johnson, Ailux, XtalPi
**Countries:** China, UK, US, Sweden, Spain

[Read the full story on The Manila Times](https://www.manilatimes.net/2026/04/10/tmt-newswire/pr-newswire/ailux-appoints-maria-belvisi-phd-as-chief-scientific-officer/2317759)

---

Canonical: https://newsio.io/n/ff2d9334-aba7-441d-aea5-7bb7b447cd81/professor-belvisi-joins-from-astrazeneca-where-she-served-as-senior-vice-preside
Summarized by Newsio from The Manila Times. https://newsio.io/how-it-works